As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India Farhat Nasim22 April 2025 7:04 PM ISTNew Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets Dr. Divya Colin17 April 2025 5:30 PM ISTNew Delhi: In line with the proposal for approval of Semaglutide tablets 1.5 mg, 4 mg, 9 mg of new formulation based on the bioequivalence (BE)...
Novo Nordisk India head eyes 2026 weight-loss drug Wegovy launch Roshni Dhar3 Oct 2023 3:24 PM ISTDanish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring...
Health Bulletin 2/ October/ 2023 Roshni Dhar2 Oct 2023 3:40 PM ISTHere are the top health stories for the day:MCC releases final result for round 3 of NEET PG, NEET MDS counsellingThe Medical Counselling Committee...
Novo Nordisk eyes to bring blockbuster weight-loss drug Wegovy to India in 2026 Ruchika Sharma1 Oct 2023 1:00 PM ISTNovo charges more than $1300 in the U.S. for a monthly supply and about 300 euros ($317) a month in Germany.
Novo Nordisk Gets CDSCO Panel Nod to study recombinant coagulation factor XIII, Novothirteen Dr. Divya Colin8 May 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Novo Nordisk has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Novo Nordisk India unveils oral Semaglutide to treat diabetes Roshni Dhar25 Jan 2022 5:53 PM ISTDrug firm Novo Nordisk India on Thursday said it has launched a first of its kind diabetes treatment medication in the country. The company said it...
Health Bulletin 25/January/2022 Roshni Dhar25 Jan 2022 5:49 PM ISTHere are Top Health stories of the day India reports 2.55 lakh daily new Covid-19 cases, lowest in a weekNEET counselling 2021 registrations: MCC...
